Literature DB >> 11239462

SC35 plays a role in T cell development and alternative splicing of CD45.

H Y Wang1, X Xu, J H Ding, J R Bermingham, X D Fu.   

Abstract

Molecular diversity via alternative splicing is important for cellular function and development. SR proteins are strong candidate regulators of alternative splicing because they can modulate splice site selection. However, endogenous substrates for SR proteins are largely unknown, and their roles as splicing regulators in vertebrate development are unclear. Here we report that Cre-mediated conditional deletion of the prototypical SR protein SC35 in the thymus causes a defect in T cell maturation. Deletion of SC35 alters alternative splicing of CD45, a receptor tyrosine phosphatase known to be regulated by differential splicing during thymocyte development and activation. This study establishes a model to address the function of SR proteins in physiological settings and reveals a critical role of SC35 in a T cell-specific regulated splicing pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239462     DOI: 10.1016/s1097-2765(01)00181-2

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  64 in total

1.  Ectopic expression of atRSZ33 reveals its function in splicing and causes pleiotropic changes in development.

Authors:  Maria Kalyna; Sergiy Lopato; Andrea Barta
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

2.  A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors.

Authors:  Valerie Edmond; Galina Merdzhanova; Stephanie Gout; Elisabeth Brambilla; Sylvie Gazzeri; Beatrice Eymin
Journal:  Cell Cycle       Date:  2013-03-21       Impact factor: 4.534

Review 3.  Post-transcriptional coordination of immunological responses by RNA-binding proteins.

Authors:  Panagiota Kafasla; Antonis Skliris; Dimitris L Kontoyiannis
Journal:  Nat Immunol       Date:  2014-06       Impact factor: 25.606

Review 4.  Regulation of splicing by SR proteins and SR protein-specific kinases.

Authors:  Zhihong Zhou; Xiang-Dong Fu
Journal:  Chromosoma       Date:  2013-03-24       Impact factor: 4.316

5.  Identification of mRNA splicing factors as the endothelial receptor for carbohydrate-dependent lung colonization of cancer cells.

Authors:  Shingo Hatakeyama; Kazuhiro Sugihara; Jun Nakayama; Tomoya O Akama; Shuk-Man Annie Wong; Hiroto Kawashima; Jianing Zhang; David F Smith; Chikara Ohyama; Minoru Fukuda; Michiko N Fukuda
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

6.  Alternative splicing is frequent during early embryonic development in mouse.

Authors:  Timothée Revil; Daniel Gaffney; Christel Dias; Jacek Majewski; Loydie A Jerome-Majewska
Journal:  BMC Genomics       Date:  2010-06-23       Impact factor: 3.969

7.  Role of CD45 signaling pathway in galactoxylomannan-induced T cell damage.

Authors:  Eva Pericolini; Elena Gabrielli; Giovanni Bistoni; Elio Cenci; Stefano Perito; Siu-Kei Chow; Francesca Riuzzi; Rosario Donato; Arturo Casadevall; Anna Vecchiarelli
Journal:  PLoS One       Date:  2010-09-14       Impact factor: 3.240

8.  Early embryonic lethality of mice lacking the essential protein SNEV.

Authors:  Klaus Fortschegger; Bettina Wagner; Regina Voglauer; Hermann Katinger; Maria Sibilia; Johannes Grillari
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

9.  The SR family proteins B52 and dASF/SF2 modulate development of the Drosophila visual system by regulating specific RNA targets.

Authors:  Mathieu Gabut; Jérôme Dejardin; Jamal Tazi; Johann Soret
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

10.  Antagonistic factors control the unproductive splicing of SC35 terminal intron.

Authors:  Natacha Dreumont; Sara Hardy; Isabelle Behm-Ansmant; Liliane Kister; Christiane Branlant; James Stévenin; Cyril F Bourgeois
Journal:  Nucleic Acids Res       Date:  2009-12-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.